US 9925188
DNA-PK inhibitors and uses thereof
granted A61KA61K31/506A61K31/53
Quick answer
US patent 9925188 (DNA-PK inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/506, A61K31/53, A61K31/5377, A61K41/0038